Fate Therapeutics
FATE
FATE
122 hedge funds and large institutions have $762M invested in Fate Therapeutics in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4.84% more ownership
Funds ownership: 87.27% → 92.1% (+4.8%)
6% more call options, than puts
Call options by funds: $2.57M | Put options by funds: $2.43M
15% less capital invested
Capital invested by funds: $893M → $762M (-$131M)
Holders
122
Holding in Top 10
5
Calls
$2.57M
Puts
$2.43M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$20M | |
| 3 | +$10.2M | |
| 4 |
DM
Deerfield Management
New York
|
+$6.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.81M |
Top Sellers
| 1 | -$27.1M | |
| 2 | -$8.34M | |
| 3 | -$6.62M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$3.69M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$3.33M |